FXR Agonist GW4064 Attenuates Weight Gain and Insulin Resistance in db/db Mice
Daily intraperitoneal treatment with the farnesoid X receptor agonist GW4064 significantly attenuated weight gain, improved insulin sensitivity, and reduced hepatic ...
Daily intraperitoneal treatment with the farnesoid X receptor agonist GW4064 significantly attenuated weight gain, improved insulin sensitivity, and reduced hepatic ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.